SOUTHWEST ASIA–(ENEWSPF)–Sept. 15, 2017 — U.S. and coalition military forces continued to attack the Islamic State of Iraq and Syria yesterday, conducting 19 strikes consisting of 30 engagements, Combined Joint Task Force Operation Inherent Resolve officials reported today. Officials reported details of yesterday’s strikes, noting that assessments of results are[Read More…]
Latest News
Union Street Gallery to Host National Collage Society’s 33rd Annual Juried Exhibition
CHICAGO HEIGHTS—(ENEWSPF)—September 15, 2017. Union Street Gallery, 1527 Otto Boulevard in Chicago Heights is hosting the National Collage Society’s 33rd Annual Juried Exhibition. The exhibit runs from Wednesday, September 27 through Saturday, October 28. There will be a reception on Friday, September 29 from 6 p.m. to 9 p.m. Both the[Read More…]
ACLU Seeks Immediate Halt to Trump’s Transgender Service Member Ban
BALTIMORE —(ENEWSPF)–September 14, 2017. The American Civil Liberties Union and the law firm Covington & Burling LLP today asked a judge to immediately halt to the Trump administration’s ban on transgender individuals serving in the U.S. military while their lawsuit challenging the ban moves through the court system. The motion[Read More…]
Watch Cassini Spacecraft’s Grand Finale Friday Morning, September 15
CALIFORNIA–(ENEWSPF)–September 14, 2017. After two decades in space, NASA’s Cassini spacecraft is nearing the end of its remarkable journey of exploration. Having expended almost every bit of the rocket propellant it carried to Saturn, operators are deliberately plunging Cassini into the planet to ensure Saturn’s moons will remain pristine for[Read More…]
Casting Call for Rapunzel at South Suburban College on Sept. 28 & 29
SOUTH HOLLAND, IL – (ENEWSPF)—September 14, 2017. The Children’s Theatre Company of South Suburban College announces open auditions for Michele L. Vacca’s “Rapunzel and the Frog Prince.” It’s a uniquely comical mashup that cleverly blends the two Grimm’s tales into one story. This isn’t your standard fairy tale! The auditions[Read More…]
Target Recalls Room Essentials 4-Drawer Dressers Due to Tip-Over and Entrapment Hazards
Washington, DC–(ENEWSPF)–September 14, 2017 Recall Summary Name of product: Room Essentials 4-drawer dressers Hazard: The recalled dressers are unstable if they are not anchored to the wall, posing serious tip-over and entrapment hazards that can result in death or injuries to children. Remedy: Refund Recall date: September 13, 2017 Recall[Read More…]
On Constitution Day Youth Present Policies to Improve Public Education, Juvenile Justice and Policing in Schools
Chicago IL—(ENEWSPF)—September 14, 2017. Over 200 youth from around the city drafted policy recommendations aimed at improving lives of youth in the city and providing policy makers the youth perspective on issues that are impacting their lives everyday. These 200 young people represent about 100 CPS high schools and are[Read More…]
FDA Approves New Treatment for Adults with Relapsed Follicular Lymphoma
Silver Spring, Maryland–(ENEWSPF)–September 14, 2017. The U.S. Food and Drug Administration today granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular lymphoma who have received at least two prior treatments known as systemic therapies. “For patients with relapsed follicular lymphoma, the cancer often comes back[Read More…]
FDA Permits Marketing of Mobile Medical Application for Substance Use Disorder
Silver Spring, Maryland–(ENEWSPF)–September 14, 2017. Today, the U.S. Food and Drug Administration permitted marketing of the first mobile medical application to help treat substance use disorders (SUD). The Reset application is intended to be used with outpatient therapy to treat alcohol, cocaine, marijuana and stimulant SUDs. The application is not[Read More…]
FDA Approves First Biosimilar for the Treatment of Cancer
Mvasi, a biosimilar to the cancer drug Avastin, is approved for certain colorectal, lung, brain, kidney and cervical cancers Silver Spring, Maryland–(ENEWSPF)–September 14, 2017. The U.S. Food and Drug Administration today approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple types of cancer. Mvasi is[Read More…]
